SnapshotNIR is enabling clinicians to drive better outcomes in wound care, limb preservation, and surgery, with its diagnostic-driven imaging technology. NEWS PROVIDED BY Kent Imaging Inc. June 21, …
Egg Medical hatches technology to shield health care workers from radiation
The Arden Hills company has landed $13 million in financing. By Burl Gilyard Star Tribune MARCH 27, 2022 — 2:00PM A Twin Cities medtech startup, Egg Medical Inc., is building up sales of a new …
Egg Medical hatches $13M VC funding
March 4, 2022 By Annette Boyle Egg Medical Inc. secured a $13 million investment from TVM Capital Life Science to solve the Humpty-Dumpty problem that plagues interventional cardiology …
Egg Medical, Inc., Closes on $13 million Financing
Egg Medical, Inc., Closes on $13 million Financing Arden Hills, MN (March 3rd, 2022) — Egg Medical, Inc., a medical device company commercializing technologies to reduce scatter radiation exposure …
CENTOGENE Announces CFO Transition and Appointment of Miguel Coego Rios as EVP Finance & Legal and Interim CFO
CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 08, 2022 (GLOBE NEWSWIRE – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, …
CENTOGENE Announces Nomination of Andreas Busch to Supervisory Board
Nomination adds significant expertise to support pharma partnerships and an impressive track record in value creation CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 1, 2022 (GLOBE …
CENTOGENE Announces USD 62 Million Aggregate Equity and Debt Financings to Support Growth Plan
Enables refocusing on core business of delivering valuable, data-driven insights to patients, and pharmaceutical companies globally EUR 15 million private placement from leading growth investors and …
CENTOGENE Announces Nomination of Kim Stratton as Chief Executive Officer
Dr. Andrin Oswald resigns as CEO due to prolonged medical leave; Kim Stratton elected as successor CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 1, 2022 (GLOBE NEWSWIRE – Centogene …
TVM Capital Life Science promotes Dr. Sascha Berger and Dr. Alain Thibault to General Partner
Munich, Germany / Montreal, Canada - 12 January 2022 – TVM Life Science (“TVM”), a leading International Life Sciences Venture Capital firm, today announces the formal promotion of Dr. Sascha Berger …
Syndivia and TVM Capital Life Science Announce Creation of Auricula Biosciences to Develop Innovative Therapy for Patients with K-Ras mutant malignancies
Luxembourg, January 13th, 2022 – TVM Life Science Innovation II SCSp announced the Fund's investment establishing Auricula Biosciences, Inc., a company based in Wilmington, Delaware, USA. Auricula …